Represented Novel Labs. Inc., now a division of Lupin Ltd., in a Hatch-Waxman patent litigation concerning a pre-colonoscopy bowel prep drug. Successfully appealed in the Federal Circuit, re-tried the case, which was appealed again, and ultimately settled.
*Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.